Timing of Hepatitis C Antiviral Therapy in Liver Transplant Recipients With Direct-acting Agents. [electronic resource]
Producer: 20170522Description: 243-51 p. digitalISSN:- 2146-8427
- Antiviral Agents -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- End Stage Liver Disease -- diagnosis
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- diagnosis
- Humans
- Liver Transplantation -- adverse effects
- Recurrence
- Risk Factors
- Sustained Virologic Response
- Time Factors
- Treatment Outcome
- Virus Activation -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.